IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 238 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $112,740 | -15.6% | 24,778 | +30.5% | 0.00% | – |
Q2 2023 | $133,633 | -3.9% | 18,982 | -16.6% | 0.00% | – |
Q1 2023 | $139,033 | -40.3% | 22,755 | +62.3% | 0.00% | – |
Q1 2022 | $233,000 | +2.2% | 14,017 | +17.6% | 0.00% | – |
Q4 2021 | $228,000 | -21.9% | 11,918 | +0.5% | 0.00% | – |
Q3 2021 | $292,000 | -12.0% | 11,854 | -7.0% | 0.00% | – |
Q2 2021 | $332,000 | -21.7% | 12,744 | -4.9% | 0.00% | – |
Q1 2021 | $424,000 | -31.7% | 13,400 | +0.1% | 0.00% | – |
Q4 2020 | $621,000 | +29.1% | 13,392 | -8.3% | 0.00% | – |
Q3 2020 | $481,000 | +34.4% | 14,612 | +12.2% | 0.00% | – |
Q2 2020 | $358,000 | +6.5% | 13,025 | +16.2% | 0.00% | – |
Q1 2020 | $336,000 | – | 11,208 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |